Global Tuberculosis (TB) Diagnostics Competitive Landscape Professional Research Report 2025
Description
Research Summary
Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.
According to DIResearch's in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Tuberculosis (TB) Diagnostics Include:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Product Segment Include:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Product Application Include:
Diagnostic Laboratories
Hospitals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis
Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter’s Five Forces Analysis
Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.
According to DIResearch's in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Tuberculosis (TB) Diagnostics Include:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Product Segment Include:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Product Application Include:
Diagnostic Laboratories
Hospitals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis
Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter’s Five Forces Analysis
Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Tuberculosis (TB) Diagnostics Market Overview
- 1.1 Product Definition and Statistica Sclope
- 1.2 Tuberculosis (TB) Diagnostics Product by Type
- 1.2.1 Culture-Based Diagnostics
- 1.2.2 Sputum Smear Microscopy
- 1.2.3 Rapid Molecular Diagnostics
- 1.2.4 Others
- 1.3 Tuberculosis (TB) Diagnostics Product by Application
- 1.3.1 Diagnostic Laboratories
- 1.3.2 Hospitals
- 1.4 Global Tuberculosis (TB) Diagnostics Market Size Analysis (2020-2032)
- 1.5 Tuberculosis (TB) Diagnostics Market Development Status and Trends
- 1.5.1 Tuberculosis (TB) Diagnostics Industry Development Status Analysis
- 1.5.2 Tuberculosis (TB) Diagnostics Industry Development Trends Analysis
- 2 Tuberculosis (TB) Diagnostics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Tuberculosis (TB) Diagnostics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Tuberculosis (TB) Diagnostics Market Analysis by Regions
- 4.1 Global Tuberculosis (TB) Diagnostics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Tuberculosis (TB) Diagnostics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Tuberculosis (TB) Diagnostics Revenue and Market Share Forecast by Region (2026-2032)
- 5 Global Tuberculosis (TB) Diagnostics Market Size by Type and Application
- 5.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2032)
- 5.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Tuberculosis (TB) Diagnostics Market Size by Type
- 6.4 North America Tuberculosis (TB) Diagnostics Market Size by Application
- 6.5 North America Tuberculosis (TB) Diagnostics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Type
- 7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Application
- 7.5 Europe Tuberculosis (TB) Diagnostics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Tuberculosis (TB) Diagnostics Market Size by Type
- 8.4 China Tuberculosis (TB) Diagnostics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Type
- 9.4 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Application
- 9.5 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Type
- 10.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Application
- 10.5 Latin America Tuberculosis (TB) Diagnostics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type
- 11.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application
- 11.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Tuberculosis (TB) Diagnostics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Danaher
- 13.1.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
- 13.1.3 Danaher Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Roche
- 13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Roche Tuberculosis (TB) Diagnostics Product Portfolio
- 13.2.3 Roche Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Thermo Fisher Scientific
- 13.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
- 13.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 BD
- 13.4.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 BD Tuberculosis (TB) Diagnostics Product Portfolio
- 13.4.3 BD Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Abbott
- 13.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
- 13.5.3 Abbott Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Hologic
- 13.6.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
- 13.6.3 Hologic Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Qiagen
- 13.7.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
- 13.7.3 Qiagen Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 BioMerieux
- 13.8.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
- 13.8.3 BioMerieux Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Hain Lifescience
- 13.9.1 Hain Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
- 13.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Oxford Immunotec
- 13.10.1 Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
- 13.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Tuberculosis (TB) Diagnostics Industry Chain Analysis
- 14.2 Tuberculosis (TB) Diagnostics Industry Raw Material and Suppliers Analysis
- 14.2.1 Tuberculosis (TB) Diagnostics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Tuberculosis (TB) Diagnostics Typical Downstream Customers
- 14.4 Tuberculosis (TB) Diagnostics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
